Former US surgeon general C. Everett Koop, MD,
and Quintiles Transnational Corp. have launched an interactive,
consumer Internet resource to enable interested individuals to sign
up online for possible participation in clinical drug trials via the www.drkoop.com
web site. This consumer service contains inter-active prescreening,
enrollment, and tracking features designed to expand awareness and
availability of clinical trials as a treatment option for consumers.
The Quintiles-drkoop.com Clinical Trials Information Center is a
joint effort between drkoop.com, the Internet health care web site,
and Quintiles, a provider of health care services to the
pharmaceutical industry and clinical trials management organization.
Visiting the Web Site
This center gives drkoop.coms 1.5 million monthly visitors
access to information about clinical trials underway to test new
investigational drugs in oncology, womens health, and other
therapeutic areas. It also features advanced online prescreening to
help identify the best candidates for further evaluation by
physicians conducting the trials, therefore increasing the efficiency
and speed of the clinical trials process.
Patient enrollment is the number one challenge in completing
clinical trials on a timely basis, said Dennis Gillings, PhD,
chairman and chief executive officer of Quintiles Transnational Corp.
I believe the Quintiles-drkoop.com Clinical Trials Information
Center will help meet this challenge while giving individuals
expanded options to manage their health care.
Clinical Trial Participants
Dr. Koop, chairman and founder of drkoop.com, said, Today, only
a small percentage of consumers are aware of clinical trials as a
health care option, both from the standpoint of receiving a high
level of care and in helping develop the latest products to treat
debilitating or life-threatening diseases.
The center, www.drkoop.com/hcr/trials, offers access to information
about a number of ongoing studies, including summaries of the trials,
inclusion and exclusion criteria, and contact information for the
closest or most appropriate clinical sites. Neither the trial
sponsors nor investigational drugs being studied are identified. The
center also includes current information about the role of clinical
trials in drug development, patients rights issues, and other
Prescreening Potential Participants
Interactive questionnaires for prescreening are a part of the
Clinical Trials Information Center. An individuals responses
are evaluated to determine whether he or she meets the trials
basic criteria. If the criteria are met, the individual will be given
information immediately about the most appropriate clinical site to
contact. No information is stored or transferred without the
individuals consent during this process. The final decision to
participate requires an evaluation and approval by the physician
investigator and the patients informed consent. Unique to the
Quintiles-drkoop.com center, interactive prescreening should increase
the likelihood that patients referred to a site are qualified to
participate in the trial.
Interested individuals who do not fit a trials inclusion
criteria receive other useful information and can consent to have
their prescreening information stored in a database and matched with
appropriate trials in the future. To protect privacy, personally
identifiable information is disclosed only to an investigator site,
only with an individuals permission, and only to help that
person participate in a clinical trial. Individuals may withdraw
their consent from participation in the program and require that
their personal information be removed from the database at any time.